IP Verse

Uses Of Bremelanotide In Therapy For Female Sexual Dysfunction

Patent No. EP2916856 (titled "Uses Of Bremelanotide In Therapy For Female Sexual Dysfunction") was filed by Palatin on Nov 5, 2013. The application was issued on Oct 18, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSJun 18, 2019HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2916856

PALATIN
Application Number
EP13851014A
Filing Date
Nov 5, 2013
Status
Patent Maintained As Amended
Sep 15, 2023
Publication Date
Oct 18, 2023
External Links
Slate, Register , Google Patents